ERG and prostate adenocarcinoma: However, although PKM2 showed relatively low expression levels in the ERG fusion, FOXA1 mutation, and SPOP mutation molecular signature of prostate adenocarcinomas, there were no significant differences in several other molecular signatures of prostate adenocarcinoma (The data comes from UALCAN).